The Medical Advisor

Wearable healthcare is entering a new phase. The first generation of wearables primarily counted steps, estimated calories, measured heart rate and tracked sleep. The next generation is moving toward continuous physiological monitoring, biochemical sensing, artificial intelligence, digital biomarkers, remote patient monitoring and increasingly hands-free interaction. In 2026, the most important development is not simply that wearables can collect more data. It is that different sensors can increasingly be combined with software and AI to interpret patterns over time. That creates the possibility of moving from tracking health toward understanding health in context . At the same time, important limitations remain. A wearable measurement is not automatically a medical diagnosis. Accuracy varies by device, sensor, population and use case, while proprietary algorithms, data privacy, calibration, adherence and clinical validation remain major challenges. A 2026 U.S. Gover...

Medically Reviewed by: Dr Frank Yap, MD | Written by:     OneDayMD Editorial Team | Last Updated:  September  2026 Introduction: The Obesity Drug Revolution Is Entering a New Phase Obesity treatment is undergoing a major transformation. Over the past decade, therapies targeting incretin hormones have reshaped clinical practice, but the next five years (2026–2030) are expected to redefine obesity medicine entirely. The field is evolving from single-hormone appetite suppression to multi-hormonal metabolic reprogramming , combining appetite control, energy expenditure, satiety signaling, and body composition regulation. This article provides a structured, evidence-based overview of the most important obesity drugs in development and clinical use, including GLP-1 receptor agonists, dual and triple agonists, amylin analogs, and emerging combination therapies. 1. The Current Standard (2024–2026): GLP-1 and Dual Incretin Therapies The foundation of modern obesity pharmac...

Since its approval for human dermatological use, ivermectin has transformed how we manage specific inflammatory and parasitic skin conditions—most notably rosacea and scabies. If you are struggling with persistent facial redness, bumps, or intense itching, understanding how ivermectin works can help you determine if it is the right addition to your skincare regimen. What is Ivermectin and How Does It Work for Skin? Ivermectin is a powerful anti-parasitic and anti-inflammatory medication available in both topical (cream) and oral (pill) forms. In dermatology, it works via a dual-action mechanism: it eliminates microscopic skin parasites while simultaneously calming the pathways that cause swelling, redness, and acne-like lesions. Topical vs. Oral Ivermectin: A Quick Reference Depending on your diagnosis, a dermatologist will prescribe either a localized cream or a systemic oral dose. Here is how they compare: Form Common Brand Names Primary Skin Co...

Key Points DMSO is a remarkably safe chemical that protects cells from otherwise fatal stressors (e.g., freezing, burning, shockwaves, ischemia) Since the heart, brain, and spinal cord are particularly vulnerable to injury, DMSO can produce miraculous results when those injuries happen Despite decades of research, many serious shortcomings exist with how we treat strokes (including brain bleeds), heart attacks, and spinal cord injuries As I will show here, had the FDA not sabotaged DMSO’s adoption, in addition to countless lives being saved, millions could have been protected from a lifetime of disability or paralysis Generated using DALL·E—OpenAI’s legacy image model Introduction If I were stranded on a desert island or knew the world was ending and I could only bring a few therapies with me, one of them, without a doubt, would be DMSO. This is because:  It effectively add...